Diagnosis relies on specific von Willebrand factor tests, and management requires a multidisciplinary approach, involving cardiology for valve replacement, gastroenterology for lesion treatment, and hematology for coagulopathy correction. The gene discussed is VWF; the disease is blood coagulation disease.